MedWire News - Dermatology - TNF antagonists have favorable benefit-risk profile for psoriasis
Links shared publicly online about this topic.
- 1,166total visits
MedWire News - Dermatology - TNF antagonists have favorable benefit-risk profile for psoriasis
MedWire News Tumor necrosis factor antagonists are more likely to be successful for the treatment of psoriasis during the initial year of treatment than they are to cause serious toxicity, quantitative benefit-risk assessment data show. MedWire News
View full resource at medwire-news.md
Tags: Dermatology, Psoriasis, Poison, News
Most Recently Shared on May 15, 2010 at 9:06 pm By:
TNF antagonists have favorable benefit-risk profile for psoriasis: Tumor necrosis factor antagonists are more like... http://bit.ly/al3vay
Advertisement
